Quick Answer
Vaxart, Inc. reported Stockholders Equity of $87.80 million for fiscal year 2025.
Vaxart, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $87.80M | +49.0% |
| 2024 | $58.92M | +1.9% |
| 2023 | $57.80M | -47.7% |
| 2022 | $110.60M | -41.0% |
| 2021 | $187.53M | +52.0% |
| 2020 | $123.40M | +852.8% |
| 2019 | $12.95M | +15.5% |
| 2018 | $11.21M | +129.0% |
| 2017 | -$38.72M | -307.1% |
| 2017 | $18.70M | +163.1% |
| 2016 | -$29.64M | -164.2% |
| 2016 | $46.20M | -33.5% |
| 2015 | $69.50M | -20.0% |
| 2014 | $86.90M | +27.8% |
| 2013 | $68.00M | +14.7% |
| 2012 | $59.30M | +0.7% |
| 2011 | $58.87M | -27.7% |
| 2011 | $81.40M | +34.4% |
| 2010 | $60.57M | -30.7% |
| 2010 | $87.40M | -10.3% |
| 2009 | $97.41M | -19.8% |
| 2008 | $121.38M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $26.76M | -60.9% | -18.6% |
| June 30, 2025 | $32.88M | -58.9% | -27.9% |
| March 31, 2025 | $45.62M | -18.1% | -22.6% |
| December 31, 2024 | $58.92M | +1.9% | -13.9% |
| September 30, 2024 | $68.44M | -4.3% | -14.5% |
| June 30, 2024 | $80.01M | -5.9% | +43.7% |
| March 31, 2024 | $55.69M | -38.0% | -3.7% |
| December 31, 2023 | $57.80M | -47.7% | -19.2% |
- Vaxart, Inc. showed an increase of +49.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, Vaxart, Inc.’s stockholders equity has declined by 27.7% (from $121.38 million to $87.80 million).
- The most recent figure is from Vaxart, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: